Real-time Experiences, Physical Activity and Biological Outcomes in Personal Recovery Residents (EMPOWER-RES)
EMPOWER-RES
Real-Time Experiences, Physical Activity And Biological Outcomes In Personal Recovery Of Residents With Mental Disorders (EMPOWER-RES): A Non-Randomized Multicentric Clinical Trial
1 other identifier
interventional
72
1 country
3
Brief Summary
The project focuses on patients with severe mental disorders (SMD) residing in Italian mental health supported accommodation (SA). Although the goal of SA is to promote personal recovery - that is, living life to the fullest of one's potential - international literature on this topic is scarce, and traditional treatments in the Italian residential system show limitations in adopting such approaches. The research hypothesis is that activating personal recovery pathways could improve the biopsychosocial outcomes of patients, caregivers, and professionals. To test this hypothesis, a non-pharmacological, non-randomized interventional trial will compare two groups: one group of individuals with SMD receiving recovery-oriented treatment, using the Mental Health Recovery Star, and another group of individuals with SMD receiving standard treatment. The Mental Health Recovery Star is a ten-pointed star-shaped tool that represents various life dimensions. Patients, together with their key professional, are expected to negotiate a score for each domain on the five-stage 'Scale of Change,' capturing and monitoring the different phases of the recovery process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2025
CompletedFirst Posted
Study publicly available on registry
April 6, 2025
CompletedStudy Start
First participant enrolled
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
December 18, 2025
December 1, 2025
2 years
March 24, 2025
December 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychosocial functioning
Personal and Social Functioning Scale (FPS): assesses four key domains (socially useful activities, personal and social relationships, self-care and hygiene, and disruptive/aggressive behaviors) with scores ranging from 0 to 100, where higher scores indicate better functioning.
at baseline and at 6 and 9 months follow-up
Secondary Outcomes (30)
Rehabilitation goals
at baseline and at 6-9 months follow-up
Stress-related parameters
at baseline and at 6-9 months follow-up
Real-time experiences
at baseline and at 6-9 months follow-up for 1 week, and partly for 6 months along the experimental or control treatment
Physical Activity-Related Parameters
for 1 week at baseline and at 6-9 months follow-up
Working alliance
at baseline and at 6-9 months follow-up
- +25 more secondary outcomes
Study Arms (2)
Recovery-oriented treatment
EXPERIMENTALA group of residents will receive a personal recovery-oriented treatment (N=36) whose key professionals have participated in specific training on personal recovery.
Standard treatment
NO INTERVENTIONA group of residents will receive standard treatment (N=36). Standard residential treatment for individuals with mental disorders includes medical, psychological, and social interventions aimed at improving symptoms, quality of life, and functioning. The approach is personalized based on the individual's diagnosis, symptoms, and community resources. Most SAs offer personalized care plans, designated key professionals, regular individual and group activities, medication management support, and healthy lifestyle promotion. However, few facilities provide continuous psychological, vocational, and social support, adequately addressing patients' real needs.
Interventions
The personal recovery-oriented treatment is the Mental Health Recovery Star (MHRS), a recovery-oriented tool developed in England to support and monitor personal recovery. It features a 10-point star representing life dimensions grouped into four areas: health, functioning, self-image, and social networks. Residents assess their progress on each point using a "Scale of Change " with five recovery stages, from feeling stuck to self-reliance. After assessment, residents and professionals set recovery goals (up to three at a time) and create a shared care plan. The MHRS shows good psychometric properties, with strong validity, consistency, and ease of use, despite some inter-rater reliability issues. It is best suited for shared rehabilitation plans rather than clinical monitoring. Peer review meetings will be provided. The personal recovery-oriented treatment will last six months and will be considered complete upon follow-up evaluation.
Eligibility Criteria
You may qualify if:
- diagnosis of a mental disorder according to DSM5TR,
- receiving treatment at an SRP of the recruiting centers,
You may not qualify if:
- moderate/severe intellectual disability,
- inability to speak and write in Italian.
- over 18 years old,
- inability to speak and write in Italian.
- working in SRPs of the recruiting centers as a psychiatrist, educator, nurse, social worker, OSS, ASA, or TeRP,
- unwillingness to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Brescia, Italy
Centro Sacro Cuore di Gesù, San Colombano al Lambro (MI)
Milan, Italy
Centro Sant'Ambrogio, Cernusco sul Naviglio (MI)
Milan, Italy
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Alessandra Martinelli, MD PhD
IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD Psychiatrist and clinical researcher
Study Record Dates
First Submitted
March 24, 2025
First Posted
April 6, 2025
Study Start
January 15, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
December 18, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- From December 2028 to Dcember 2029
- Access Criteria
- De-identified clinical and biological data from this non-randomized multicenter trial will be available in secure public repositories to support open science. * Eligibility: Access is granted for research aligned with study objectives, including secondary and meta-analyses. Requests must detail statistical methods, subject to independent review. * Privacy \& Security: Data will comply with protection regulations, stored only in repositories with strong cybersecurity measures. * Access Process: Researchers must submit a formal request and sign a Data Sharing Agreement (DSA) before access is granted. Authentication via the repository's system is required. * Review \& Approval: Requests will be evaluated by the study lead (or representative) based on scientific merit, ethical compliance, and feasibility.
To promote open, transparent, and collaborative science, the raw data from all studies conducted at the IRCCS Fatebenefratelli will be published in publicly accessible repositories, as required by the scientific community and funding bodies, including the Ministry of Health and the European Commission. The raw clinical and biological data related to participants in this research, a non-randomized multicenter non-pharmacological clinical trial, will be published in a form that ensures the protection of participants' privacy in accordance with current regulations. Repositories will be selected that allow access to the information only after authentication of the access request and validation by the study responsible (or a designated representative) of the reasons for the request. The public repository will also be chosen based on the cybersecurity and data protection guarantees it offers.